Erasca is looking for a refresh as it drops several early-stage cancer assets, picks up new ones from China and raises cash ...
Bayer shared more data on its menopause symptom drug elinzanetant, which demonstrates how the treatment triumphed over ...
The European Patent Office on Thursday handed a win to Moderna in a long-running patent battle with Pfizer and BioNTech over ...
Telix Pharmaceuticals, a radiopharma drug and diagnostics maker, has started its march toward a listing on the Nasdaq, ...
The European Medicines Agency is taking aim at preterm birth drugs, with the agency’s safety committee recommending that ...
Korean biotech HLB and its China-based partner Jiangsu Hengrui Pharmaceuticals said Friday that the FDA rejected their drug ...
Jim Burns was looking for his next post after his latest venture in biotech, a gene therapy startup known as Locanabio, shut ...
Rapport Therapeutics, which emerged out of Johnson & Johnson's neuroscience unit last year, has submitted its pitch for a ...
The FDA has work to do to earn the confidence of certain groups of people who do not trust the agency, a study published ...
In a new analysis of Novo Nordisk’s vast SELECT study, researchers may have a better answer for one of the biggest questions ...
Facing a challenging launch for the Alzheimer’s drug Leqembi, Biogen CEO Chris Viehbacher said he would welcome competition ...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...